The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Okey Stephanie since 2020.
This trader's CIK number is 1742616.
At the time of last reporting, Okey Stephanie was the Director of Crinetics Pharmaceuticals, Inc.. (stock ticker symbol CRNX).
Also see all insider trading activities at Crinetics Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | CRNX | 0 | $0 | 12,000 | $476,040 | 0 | $0 |
| 2024 | CRNX | 0 | $0 | 17,500 | $811,650 | 17,500 | $320,075 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | PTCT | 0 | $0 | 5,000 | $270,000 | 0 | $0 |
| 2022 | PTCT | 0 | $0 | 2,296 | $118,521 | 0 | $0 |
| 2021 | PTCT | 0 | $0 | 1,650 | $66,094 | 0 | $0 |
| 2020 | PTCT | 0 | $0 | 687 | $42,953 | 0 | $0 |
1. Crinetics Pharmaceuticals, Inc. (CRNX)
2. Ptc Therapeutics, Inc. (PTCT)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-03-03 | CRNX | Sale | 3,000 | 39.67 | 119,010 |
| 2026-03-03 | CRNX | Sale | 3,000 | 39.67 | 119,010 |
| 2026-03-03 | CRNX | Sale | 3,000 | 39.67 | 119,010 |
| 2026-03-03 | CRNX | Sale | 3,000 | 39.67 | 119,010 |
| 2024-03-28 | CRNX | Option Ex | 17,500 | 18.29 | 320,075 |
| 2024-03-28 | CRNX | Sale | 17,500 | 46.38 | 811,650 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-13 | PTCT | Sale | 5,000 | 54.00 | 270,000 |
| 2022-08-09 | PTCT | Sale | 2,296 | 51.62 | 118,521 |
| 2021-08-13 | PTCT | Sale | 1,650 | 40.06 | 66,094 |
| 2020-12-08 | PTCT | Sale | 687 | 62.52 | 42,953 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Okey Stephanie (Director of Crinetics Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.